26 April 2013 - Deborah Wilkes
Archived
Valeant Pharmaceuticals International has acquired Obagi Medical Products, after raising its takeover offer by more than a fifth to around US$420 million.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.